Citations

Mayo Clinic

Showing 10 of 108602 citations.

Considerations in physical therapy management of a non-responding patient with low back pain
Madson, Timothy J.

Physiotherapy Theory and Practice | July 22, 2017 | Volume: 33 | Issue: 9 | Pages: 743-750

10.1080/09593985.2017.1331480 | PMID 28727922 Get It

Response by Brinjikji et al to Letter Regarding Article, “Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke”
Brinjikji, Waleed , Kallmes, David F. , Rabinstein, Alejandro A.

Stroke | July 22, 2017 | Volume: 48 | Issue: 9 | Pages: No page available

10.1161/strokeaha.117.018458 | PMID 28733480 Get It

Serum Soluble Epidermal Growth Factor Receptor Concentrations Decrease in Postmenopausal Metastatic Breast Cancer Patients Treated with Letrozole
Lafky, Jacqueline M., Cora, Elsa M., Perez, Edith A. , Maihle, Nita J. , Baron, Andre T. , Hillman, David W. , Suman, Vera J. , Ingle, James N.

Cancer Research | July 21, 2017 | Volume: 65 | Issue: 8 | Pages: 3059-3062

10.1158/0008-5472.can-05-0067 | PMID 15833834 Get It

Abstract Previous studies have implicated estrogen as a regulator of epidermal growth factor receptor (EGFR) expression in breast tumors. We therefore speculated that estrogen might modulate serologic soluble EGFR (sEGFR) concentrations in breast cancer patients. Accordingly, we measured serum sEGFR concentrations in postmenopausal women with metastatic breast cancer (MBC) treated with letrozole, an aromatase inhibitor that blocks estrogen synthesis. Serum specimens were obtained prior to and following 1 and 3 months of letrozole therapy. We report that sEGFR concentrations do not differ between MBC patients prior to letrozole treatment and age- and postmenopause-matched healthy women (P = 0.468). In contrast, however, sEGFR concentrations decreased significantly in 76% of MBC patients after both 1 month (P = 0.006) and 3 months (P = 0.003) of letrozole therapy versus pretreatment concentrations. Within the limitations of this study, we found no evidence for an association between pretreatment sEGFR concentrations or decreased treatment sEGFR concentrations and either progression-free or overall survival. Nonetheless, we conclude that future prospective studies are warranted to determine if baseline and/or longitudinal serum sEGFR concentrations may be useful for predicting disease progression and survival, and/or for monitoring responsiveness to aromatase inhibitors or other endocrine therapies in breast cancer patients.
Experimental Design and Analysis of Antibody Microarrays: Applying Methods from cDNA Arrays
Eckel‐Passow, Jeanette E. , Hoering, Antje , Therneau, Terry M. , Ghobrial, Irene M.

Cancer Research | July 21, 2017 | Volume: 65 | Issue: 8 | Pages: 2985-2989

10.1158/0008-5472.can-04-3213 | PMID 15833819 Get It

Abstract Protein expression microarrays, also called antibody arrays, represent a new technology that allows the expression level of proteins to be assessed directly. As is also the case with gene expression microarrays, it is hoped that protein expression microarrays will aid in biomarker discovery, predicting disease outcomes and response to treatments, and detecting molecular mechanisms and/or pathways associated with a particular disease state. However, accurately achieving these aims is dependent upon suitable experimental designs, normalization procedures that eliminate systematic bias, and appropriate statistical analyses to assess differential expression or expose expression patterns. In the last five years, a large amount of research has been devoted to two-color cDNA arrays to improve experimental design, normalization and statistical analyses to assess differential expression and classification. These methods are directly applicable to two-color antibody arrays. The objective of this article is to discuss statistical methods that have been developed for cDNA arrays and describe how the methods can be directly applied to antibody arrays.
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma
Connors, Joseph M. , Ansell, Stephen M. , Fanale, Michelle A. , Park, Steven I., Younes, Anas , Park, Steven , Connors, Joseph M , Park, Steven I

Blood | July 21, 2017 | Volume: 130 | Issue: 11 | Pages: 1375-1377

10.1182/blood-2017-05-784678 | PMID 28733323 Get It

Upscaling Uncertainty with Dynamic Discrepancy for a Multi-Scale Carbon Capture System
Bhat, K. Sham , Mahapatra, Priyadarshi, Storlie, Curtis B. , Mebane, David S.

Journal of the American Statistical Association | July 21, 2017 | Volume: 112 | Issue: 520 | Pages: 1453-1467

10.1080/01621459.2017.1295863 Get It

Local Cellular Responses to Titanium Dioxide from Orthopedic Implants
Yao, Jie , Lewallen, Eric A. , Trousdale, William H. , Xu, Wei , Thaler, Roman , Salib, Christopher G. , Reina, Nicolas , Lewallen, David G. , Wijnen, André J. van , Yao, Jie J, Abdel, Matthew P. , van Wijnen, Andre J

BioResearch Open Access | July 21, 2017 | Volume: 6 | Issue: 1 | Pages: 94-103

10.1089/biores.2017.0017 | PMID 29034133 Get It

Social network analysis of a scientist–practitioner research initiative established to facilitate science dissemination and implementation within states and communities
Ginexi, Elizabeth M. , Huang, Grace C. , Steketee, Michael, Tsakraklides, Sophia, MacAllum, Keith, Bromberg, Julie , Huffman, Amanda, Luke, Douglas A. , Leischow, Scott J. , Rogers, Todd , Okamoto, Janet

Research Evaluation | July 21, 2017 | Volume: 26 | Issue: 4 | Pages: 316-325

10.1093/reseval/rvx026 Get It

Does hospital ownership influence hospital referral region health rankings in the United States
Hamadi, Hanadi , Apatu, Emma , Spaulding, Aaron , Spaulding, Aaron , Hamadi, Hanadi Y

The International Journal of Health Planning and Management | July 21, 2017 | Volume: 33 | Issue: 1 | Pages: No page available

10.1002/hpm.2442 | PMID 28731547 Get It

SummaryExtensive evidence demonstrates that a hospital's organizational ownership structure impacts its overall performance, but little is known concerning the influence of hospital structure on the health of its community. This paper explores the association between US hospital referral region (HRR) health rankings and hospital ownership and performance. Data from the 2016 Commonwealth Fund Scorecard on Local Health System Performance, the American Hospital Association dataset, and the Hospital Value‐Based Purchasing dataset are utilized to conduct a cross‐sectional analysis of 36 quality measures across 306 HRRs. Multivariate regression analysis was used to estimate the association among hospital ownership, system performance measures—access and affordability, prevention and treatment, avoidable hospital use and cost, and healthy lives—and performance as measured by value‐based purchasing total performance scores. We found that indicators of access and affordability, as well as prevention and treatment, were significantly associated across all 3 hospitals' organizational structures. Hospital referral regions with a greater number of not‐for‐profit hospitals demonstrated greater indications of access and affordability, as well as better prevention and treatment rankings than for‐profit and government hospitals. Hospital referral regions with a greater number of government, nonfederal hospitals had worse scores for healthy lives. Furthermore, the greater the total performance scores score, the better the HRR score on prevention and treatment rankings. The greater the per capita income, the better the score across all 4 dimensions. As such, this inquiry supports the assertion that performance of a local health system is dependent on its community's resources of health care delivery entities and their structure.
Histologic scoring indices for evaluation of disease activity in Crohn’s disease
Novak, Gregor , Parker, Claire E. , Pai, Rish K. , MacDonald, John K, Feagan, Brian G. , Sandborn, William J. , D’Haens, Geert , Khanna, Reena , Jairath, Vipul

Cochrane Database of Systematic Reviews | July 21, 2017 | Volume: 2017 | Issue: 7 | Pages: No page available

10.1002/14651858.cd012351.pub2 | PMID 28731502 Get It